Literature DB >> 26278393

Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.

Mohamed A Abdelmegeed1, Seung-Kwon Ha2, Youngshim Choi2, Mohammed Akbar2, Byoung-Joon Song2.   

Abstract

Alcoholic fatty liver disease (AFLD) and non-alcoholic fatty liver disease (NAFLD) are two pathological conditions that are spreading worldwide. Both conditions are remarkably similar with regard to the pathophysiological mechanism and progression despite different causes. Oxidative stressinduced mitochondrial dysfunction through post-translational protein modifications and/or mitochondrial DNA damage has been a major risk factor in both AFLD and NAFLD development and progression. Cytochrome P450-2E1 (CYP2E1), a known important inducer of oxidative radicals in the cells, has been reported to remarkably increase in both AFLD and NAFLD. Interestingly, CYP2E1 isoforms expressed in both endoplasmic reticulum (ER) and mitochondria, likely lead to the deleterious consequences in response to alcohol or in conditions of NAFLD after exposure to high fat diet (HFD) and in obesity and diabetes. Whether CYP2E1 in both ER and mitochondria work simultaneously or sequentially in various conditions and whether mitochondrial CYP2E1 may exert more pronounced effects on mitochondrial dysfunction in AFLD and NAFLD are unclear. The aims of this review are to briefly describe the role of CYP2E1 and resultant oxidative stress in promoting mitochondrial dysfunction and the development or progression of AFLD and NAFLD, to shed a light on the function of the mitochondrial CYP2E1 as compared with the ER-associated CYP2E1. We finally discuss translational research opportunities related to this field. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Alcoholic fatty liver disease; CYP2E1; lipid peroxidation; mitochondria; mitochondrial dysfunction; non-alcoholic fatty liver disease; oxidative stress; post-translational protein modification

Mesh:

Substances:

Year:  2017        PMID: 26278393      PMCID: PMC4757513          DOI: 10.2174/1874467208666150817111114

Source DB:  PubMed          Journal:  Curr Mol Pharmacol        ISSN: 1874-4672            Impact factor:   3.339


  254 in total

1.  Mitochondrial targeted cytochrome P450 2E1 (P450 MT5) contains an intact N terminus and requires mitochondrial specific electron transfer proteins for activity.

Authors:  M A Robin; H K Anandatheerthavarada; J K Fang; M Cudic; L Otvos; N G Avadhani
Journal:  J Biol Chem       Date:  2001-04-26       Impact factor: 5.157

Review 2.  Hepatoprotective effects of S-adenosyl-L-methionine against alcohol- and cytochrome P450 2E1-induced liver injury.

Authors:  Arthur I Cederbaum
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

3.  Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling.

Authors:  Jörn M Schattenberg; Yongjun Wang; Rajat Singh; Raina M Rigoli; Mark J Czaja
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

4.  Rat liver mitochondrial damage under acute or chronic carbon tetrachloride-induced intoxication: protection by melatonin and cranberry flavonoids.

Authors:  V T Cheshchevik; E A Lapshina; I K Dremza; S V Zabrodskaya; R J Reiter; N I Prokopchik; I B Zavodnik
Journal:  Toxicol Appl Pharmacol       Date:  2012-04-14       Impact factor: 4.219

5.  ATP consumption by sarcoplasmic reticulum Ca2+ pumps accounts for 50% of resting metabolic rate in mouse fast and slow twitch skeletal muscle.

Authors:  Sarah Michelle Norris; Eric Bombardier; Ian Curtis Smith; Chris Vigna; Allan Russell Tupling
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-16       Impact factor: 4.249

6.  Role for intestinal CYP2E1 in alcohol-induced circadian gene-mediated intestinal hyperpermeability.

Authors:  Christopher B Forsyth; Robin M Voigt; Maliha Shaikh; Yueming Tang; Arthur I Cederbaum; Fred W Turek; Ali Keshavarzian
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-05-09       Impact factor: 4.052

7.  High-fat diet decreases activity of the oxidative phosphorylation complexes and causes nonalcoholic steatohepatitis in mice.

Authors:  Inmaculada García-Ruiz; Pablo Solís-Muñoz; Daniel Fernández-Moreira; Montserrat Grau; Francisco Colina; Teresa Muñoz-Yagüe; José A Solís-Herruzo
Journal:  Dis Model Mech       Date:  2014-09-26       Impact factor: 5.758

Review 8.  CYP2E1 autoantibodies in liver diseases.

Authors:  Salvatore Sutti; Cristina Rigamonti; Matteo Vidali; Emanuele Albano
Journal:  Redox Biol       Date:  2014-11-18       Impact factor: 11.799

9.  Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants.

Authors:  Matthias L Jauslin; Thomas Meier; Robin A J Smith; Michael P Murphy
Journal:  FASEB J       Date:  2003-08-15       Impact factor: 5.191

10.  Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis.

Authors:  Wei Wang; Caiyan Zhao; Junying Zhou; Zhen Zhen; Yadong Wang; Chuan Shen
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

View more
  18 in total

1.  1,3-Butadiene-induced mitochondrial dysfunction is correlated with mitochondrial CYP2E1 activity in Collaborative Cross mice.

Authors:  Jessica H Hartman; Grover P Miller; Andres A Caro; Stephanie D Byrum; Lisa M Orr; Samuel G Mackintosh; Alan J Tackett; Lee Ann MacMillan-Crow; Lance M Hallberg; Bill T Ameredes; Gunnar Boysen
Journal:  Toxicology       Date:  2017-01-09       Impact factor: 4.221

2.  Cytochrome P450-2E1 is involved in aging-related kidney damage in mice through increased nitroxidative stress.

Authors:  Mohamed A Abdelmegeed; Youngshim Choi; Seung-Kwoon Ha; Byoung-Joon Song
Journal:  Food Chem Toxicol       Date:  2017-08-24       Impact factor: 6.023

3.  Diet high in fructose promotes liver steatosis and hepatocyte apoptosis in C57BL/6J female mice: Role of disturbed lipid homeostasis and increased oxidative stress.

Authors:  Youngshim Choi; Mohamed A Abdelmegeed; Byoung-Joon Song
Journal:  Food Chem Toxicol       Date:  2017-03-01       Impact factor: 6.023

4.  The TIR/BB-loop mimetic AS-1 prevents non-alcoholic steatohepatitis and hepatic insulin resistance by inhibiting NLRP3-ASC inflammasome activation.

Authors:  Xiaolu Wang; Yun Gao; Juan Song; Chao Tang; Man Wang; Linli Que; Li Liu; Guoqing Zhu; Qi Chen; Yong Yao; Yong Xu; Jiantao Li; Yuehua Li
Journal:  Br J Pharmacol       Date:  2017-04-26       Impact factor: 8.739

Review 5.  Mitochondria and the NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis.

Authors:  Sandra Torres; Paula Segalés; Carmen García-Ruiz; José C Fernández-Checa
Journal:  Cells       Date:  2022-04-27       Impact factor: 7.666

6.  Chemical Components and Hepatoprotective Mechanism of Xwak Granule in Mice Treated with Acute Alcohol.

Authors:  Li Chen; Liu Liu; Rahima Abdulla; Xirali Tursun; Xuelei Xin; Haji Akber Aisa
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-28       Impact factor: 2.629

Review 7.  Molecular pathways of nonalcoholic fatty liver disease development and progression.

Authors:  Fernando Bessone; María Valeria Razori; Marcelo G Roma
Journal:  Cell Mol Life Sci       Date:  2018-10-20       Impact factor: 9.261

Review 8.  Utility of Common Marmoset (Callithrix jacchus) Embryonic Stem Cells in Liver Disease Modeling, Tissue Engineering and Drug Metabolism.

Authors:  Rajagopal N Aravalli; Clifford J Steer
Journal:  Genes (Basel)       Date:  2020-06-30       Impact factor: 4.096

9.  Hepatic Differentiation of Marmoset Embryonic Stem Cells and Functional Characterization of ESC-Derived Hepatocyte-Like Cells.

Authors:  Rajagopal N Aravalli; Daniel P Collins; Joel H Hapke; Andrew T Crane; Clifford J Steer
Journal:  Hepat Med       Date:  2020-02-13

Review 10.  Fat and Sugar-A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver Disease.

Authors:  Ines C M Simoes; Justyna Janikiewicz; Judith Bauer; Agnieszka Karkucinska-Wieckowska; Piotr Kalinowski; Agnieszka Dobrzyń; Andrzej Wolski; Maciej Pronicki; Krzysztof Zieniewicz; Paweł Dobrzyń; Marcin Krawczyk; Hans Zischka; Mariusz R Wieckowski; Yaiza Potes
Journal:  Nutrients       Date:  2019-11-24       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.